These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30338558)

  • 21. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
    Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of topical calcipotriol in management of alopecia areata: A pilot study.
    Narang T; Daroach M; Kumaran MS
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Letter: Alopecia areata during ustekinumab administration: Co-existence or an adverse reaction?
    Verros C; Rallis E; Crowe M
    Dermatol Online J; 2012 Jul; 18(7):14. PubMed ID: 22863636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients.
    Orecchia G; Malagoli P; Santagostino L
    Pediatr Dermatol; 1994 Mar; 11(1):65-8. PubMed ID: 8170854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bimatoprost versus Mometasone Furoate in the Treatment of Scalp Alopecia Areata: A Pilot Study.
    Zaher H; Gawdat HI; Hegazy RA; Hassan M
    Dermatology; 2015; 230(4):308-13. PubMed ID: 25765294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined microneedling with topical vitamin D3 or bimatoprost versus microneedling alone in the treatment of alopecia areata: A comparative randomized trial.
    Ali MS; Hafiz HSA; Ahmed NA; Galal SA
    J Cosmet Dermatol; 2023 Apr; 22(4):1286-1296. PubMed ID: 36762396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alopecia areata: Part 2: treatment.
    Spano F; Donovan JC
    Can Fam Physician; 2015 Sep; 61(9):757-61. PubMed ID: 26371098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regrowth of black hair in two red-haired alopecia areata patients.
    Ramot Y; Sinclair RD; Zlotogorski A
    Australas J Dermatol; 2012 Nov; 53(4):e91-2. PubMed ID: 23157795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: a pilot study.
    Sasmaz S; Arican O
    Am J Clin Dermatol; 2005; 6(6):403-6. PubMed ID: 16343028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical observations in alopecia areata: Implications and hypotheses.
    Li J; Sinclair R
    Australas J Dermatol; 2016 Feb; 57(1):e29-31. PubMed ID: 25179296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata.
    Guttman-Yassky E; Nia JK; Hashim PW; Mansouri Y; Alia E; Taliercio M; Desai PN; Lebwohl MG
    Arch Dermatol Res; 2018 Oct; 310(8):607-614. PubMed ID: 30121698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
    Inui S; Nakajima T; Toda N; Itami S
    J Dermatol; 2009 Jun; 36(6):323-7. PubMed ID: 19500180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of alopecia areata: modern principles and perspectives].
    Brajac I; Kastelan M; Perisa D; Simonić E; Stojnić-Sosa L; Massari LP
    Lijec Vjesn; 2010; 132(11-12):365-9. PubMed ID: 21294327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current and future treatments of alopecia areata and trichotillomania in children.
    Iorizzo M; Oranje AP
    Expert Opin Pharmacother; 2016 Sep; 17(13):1767-73. PubMed ID: 27484130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism.
    Guttman-Yassky E; Ungar B; Noda S; Suprun M; Shroff A; Dutt R; Khattri S; Min M; Mansouri Y; Zheng X; Estrada YD; Singer GK; Suarez-Farinas M; Krueger JG; Lebwohl MG
    J Allergy Clin Immunol; 2016 Jan; 137(1):301-304. PubMed ID: 26607705
    [No Abstract]   [Full Text] [Related]  

  • 37. Alteration in hair texture following regrowth in alopecia areata: a case report.
    Valins W; Vega J; Amini S; Woolery-Lloyd H; Schachner L
    Arch Dermatol; 2011 Nov; 147(11):1297-9. PubMed ID: 21768446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alopecia areata.
    Perera E; Yip L; Sinclair R
    Curr Probl Dermatol; 2015; 47():67-75. PubMed ID: 26370645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple courses of pulse corticosteroid therapy for alopecia areata.
    Yoshimasu T; Kanazawa N; Yamamoto Y; Furukawa F
    J Dermatol; 2016 Sep; 43(9):1075-7. PubMed ID: 27095016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis.
    Putterman E; Castelo-Soccio L
    J Am Acad Dermatol; 2018 Jun; 78(6):1207-1209.e1. PubMed ID: 29754888
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.